Duchenne Muscular Dystrophy Awareness Day

September 7th is marked as the Duchenne Awareness Day around the world.

Muscular dystrophies are a group of genetic conditions characterized by progressive muscle weakness and atrophy. The Duchenne muscular dystrophy (DMD) primarily affects skeletal muscles which are used for movement and also cardiac muscle. This rare and fatal disease occurs once in every 3,500 newborn males in the world.

By raising awareness all around the world we may give hope to thousands of children and their families that the malady they are suffering from will be closely studied and treatment options will continue to evolve.  Please visit the official DMD web site at http://www.worldduchenneday.org/ to get more information.

The GCT team offers its experience in clinical research studies for new treatment options of a number of these rare diseases. Please contact us at bd@gctrials.com and we will leap into action to organize your clinical study in DMD and any other rare disease.

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

About

GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login

 

GCT

© 2001—2019 Global Clinical Trials, LLC

All rights reserved.